Singapore markets close in 6 hours 36 minutes

Roche Holding AG (RHHBY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
47.03+0.61 (+1.31%)
At close: 3:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous close46.42
Open46.93
BidN/A x N/A
AskN/A x N/A
Day's range46.82 - 47.25
52-week range39.72 - 48.79
Volume921,005
Avg. volume1,285,657
Market cap329.226B
Beta (5Y monthly)0.25
PE ratio (TTM)21.31
EPS (TTM)2.21
Earnings dateN/A
Forward dividend & yield1.22 (2.60%)
Ex-dividend date18 Mar 2021
1y target est50.90
  • Pharma Stock Roundup: JNJ, NVS Q2 Earnings, PFE, ABBV, LLY & MRK FDA Updates
    Zacks

    Pharma Stock Roundup: JNJ, NVS Q2 Earnings, PFE, ABBV, LLY & MRK FDA Updates

    J&J (JNJ) and Novartis (NVS) announce Q2 results. FDA delays decisions on JAK inhibitor drugs of Lilly (LLY), AbbVie (ABBV) and Pfizer (PFE) for eczema indication.

  • Roche's (RHHBY) 1H21 Sales Rise Despite Impact of Biosimilars
    Zacks

    Roche's (RHHBY) 1H21 Sales Rise Despite Impact of Biosimilars

    Roche's (RHHBY) performance in first-half 2021 was impressive on strong demand for new medicines and COVID-19 test kits. Impact of biosimilars continues to hurt sales.

  • COVID-19 tests boost Roche sales but demand expected to weaken
    Reuters

    COVID-19 tests boost Roche sales but demand expected to weaken

    ZURICH (Reuters) -Swiss drugmaker Roche said on Thursday that strong demand for COVID-19 tests had helped it rebound from a weak start to the year, as it posted better-than-expected sales for the first half. However, the Basel-based company flagged an anticipated slowdown in demand for the tests, which have helped it fare better than some drugmakers as the number of routine hospital visits and demand for other medicines fell during the pandemic. "As expected, demand for COVID-19 tests peaked in the second quarter and is likely to decrease in the second half of the year (although this) depends on how the pandemic develops," Chief Executive Severin Schwan said on a call with reporters, adding that there were still significant uncertainties.